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Combined Deletion of CD8 Locus
cis-Regulatory Elements Affects Initiation
but Not Maintenance of CD8 Expression
mocytes toward the helper and cytotoxic T cell lineages
is still largely unknown (Basson and Zamoyska, 2000;
von Boehmer, 2000). It has been shown that the func-
tional phenotype of the differentiated T cell lineage cor-
relates with the expression of the coreceptor molecules
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control mechanisms during T cell development but also
may help to understand the molecular basis of lineage
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During the last decade, the major cis-regulatory ele-
ments involved in the transcriptional regulation of CD4Developmental stage-, subset-, and lineage-specific
have been identified. A T cell-specific enhancer locatedCD8 enhancers have been identified recently by trans-
13 kb upstream of the CD4 promoter directs expressiongenic reporter analyses. Enhancer E8II (CIV-4,5) is ac-
of CD4 in both CD4 helper and CD8 cytotoxic T cellstive in both immature double-positive thymocytes (DP)
(Sawada and Littman, 1991), while a silencer elementand mature CD8 single-positive (SP) thymocytes and
located in the first intron of CD4 provides subset speci-T cells, whereas E8I (CIII-1,2) directs expression only
ficity by silencing the transcription of CD4 in CD8T cellsin mature cells. In mice lacking either E8I (CIII-1,2) or
(Donda et al., 1996; Sawada et al., 1994; Siu et al., 1994).E8II (CIV-4,5), there was no effect on CD8 expression in
The major elements involved in the transcriptional regu-DP thymocytes. However, deletion of both enhancers
lation of CD8 expression have only recently been identi-resulted in variegated expression of CD8, with appear-
fied (for review see Ellmeier et al., 1999). Thymus-derivedance of CD4CD8 SP thymocytes expressing surface
T cells usually express CD8 and CD8 heterodimersmarkers characteristic of DP thymocytes. Conse-
on their surface, while extrathymically derived intraepi-quently, fewer mature CD8 T cells developed from
thelial lymphocytes (IEL) from the gut express onlythe reduced pool of DP cells. These results suggest
CD8homodimers (Jarry et al., 1990; Lefrancois, 1991).that the initiation of CD8 expression is mediated by
This partially overlapping but distinct expression patterncis-regulatory elements that are distinct from any that
of the closely linked CD8 and CD8 genes (Gorman etmay be involved in maintenance of expression.
al., 1988) indicates that their expression must be both
coordinately and independently regulated. Hence, inde-Introduction
pendent enhancers specific either for CD8 or CD8
may exist. By applying a transgenic reporter expressionThe development of T cells expressing the  T cell
assay, several enhancers and genomic fragments in-
receptor (TCR) specific for classical major histocompati-
volved in the regulation of CD8 expression have been
bility complex (MHC) molecules is probably one of the
identified (Ellmeier et al., 1997, 1998; Hostert et al.,
best-described developmental systems in vertebrates. 1997b, 1998; Zhang et al., 1998). Four different genomic
Several developmental stages and checkpoints have fragments isolated from the CD8 locus individually were
been defined based on the expression of the CD4 and able to direct expression in a developmental stage-,
CD8 coreceptor molecules. The majority of mature pe- subset-, and lineage-specific mode (Figure 1A). One en-
ripheral T cells express either CD4 or CD8. The former hancer, designated E8I (CIII-1,2), had activity only in
constitute the helper T cell lineage and express a TCR mature CD8 T cells, while another one, E8III (CIV-3),
that together with CD4 is able to recognize foreign pep- directed expression only in immature DP thymocytes.
tide presented by MHC class II molecules, while the Enhancer E8II (CIV-4,5) directed expression both in DP
latter display a cytotoxic phenotype and are MHC class thymocytes and CD8 T cells, and an additional cis-
I restricted. These single-positive (SP) cells develop in regulatory element, E8IV (CIV-1,2), also showed low activ-
the thymus from a common CD4CD8 double-positive ity in CD4 T cells in addition to CD8 T cells. While all
(DP) progenitor cell through positive selection of those the cis-acting elements were active in thymic-derived
cells that have TCRs with appropriate avidity for MHC/ T cells (at least at certain developmental stages), only E8I
peptide complexes (Berg and Kang, 2001; Rothenberg, (CIII-1,2) directed expression of CD8 in extrathymically
2000). Despite the large number of studies, the molecu- derived IEL (Ellmeier et al., 1997). Taken together, these
lar mechanism underlying the development of DP thy- studies indicate a complex regulatory network to
achieve lineage-specific regulation of CD8 and CD8
gene expression during T cell development. The results4 Correspondence: wilfried.ellmeier@univie.ac.at
Immunity
624
Figure 1. Targeting Strategy for the Deletion
of the Enhancer E8II (CIV-4,5)
(A) Schematic map of the CD8 locus with clus-
ters of DNase I hypersensitivity sites. Hori-
zontal arrows indicate the transcriptional ori-
entation of the CD8 and CD8 genes.
Vertical arrows indicate the localization of
DNase I hypersensitivity sites that constitute
clusters II, III, and IV (Hostert et al., 1997a).
Shaded circles indicate enhancers E8I (CIII-
1,2) (divided into subregions E8IA and E8IB),
E8II (CIV-4,5), E8III (CIV-3), and E8IV (CIV-1,2),
as shown previously (Ellmeier et al., 1998). All
BamHI (B), but only relevant EcoRI (E) sites
are shown.
(B) Schematic map of the targeting construct
(top), the CD8 locus before and after homolo-
gous recombination (middle), and the geno-
mic locus after Cre recombinase-mediated
deletion of the neomycin resistance gene
(bottom). Only restriction sites important for
the targeting strategy are shown. The hori-
zontal thick black line (in the top, lower mid-
dle, and bottom) indicates the region of ho-
mology between the targeting construct and
the endogenous locus. The bars with aster-
isks (in the upper middle) represent the 5 and
3 probes used for Southern blotting. Hori-
zontal bars with numbers (indicating the size
in kb) represent the expected genomic frag-
ments after digestion with the appropriate re-
striction enzymes (XhoI and SalI for the 5
targeted region).
(C) Southern blot of XhoI/SalI-digested DNA
isolated from a wild-type ES cell clone (/),
from ES cell clones after homologous recom-
bination (/N2), and from an ES cell clone
after Cre recombinase-mediated deletion of
the neomycin resistance cassette (/2). The
origin of the detected fragments is indicated
in (B).
(D) Map of the CD8 locus showing the re-
maining enhancers and DNase I hypersensitivity sites after the deletion of enhancers E8I (CIII-1,2) and E8II (CIV-4,5). It was confirmed by
Southern blotting that no additional alteration, such as inversion of the genomic fragment flanked by the two remaining loxP sites, occurred
at the CD8 locus (data not shown).
from the transgenic reporter expression assays raise pression of CD8, both in thymus-derived T cells and in
IELs, and had no thymic developmental alterations. Thisthe question of why so many different cis-acting ele-
ments are required for the regulation of CD8 expression. indicated that other regulatory elements at the CD8 lo-
cus are sufficient to direct normal expression of CD8 inTo investigate whether different elements have unique
regulatory functions, we and others have begun a sys- the absence of E8II (CIV-4,5). Since in transgenic mice
both E8I (CIII-1,2) and E8II (CIV-4,5) direct expression intematic deletional analysis of enhancers in the mouse
germ line (Ellmeier et al., 1998; Hostert et al., 1998). mature CD8 T cells, we generated E8I (CIII-1,2)/E8II
(CIV-4,5) double-deficient mice (12/12 mice) to testThe generation of E8I (CIII-1,2)-deficient (1/1) mice
revealed that E8I (CIII-1,2) is the major cis-regulatory whether these two enhancers are able to compensate
for each other. In contrast to individual deletions, dele-element that directs CD8 expression in extrathymically
derived IELs. In contrast, thymic-derived T cell lineages tion of both enhancers had a major effect on the expres-
sion of CD8 during thymocyte development but not infrom these mutant mice displayed a normal expression
pattern of CD8, indicating that other elements are able mature CD8 lineage cells. A population of “CD8-nega-
tive” SP thymocytes appeared that was indistinguish-to compensate for loss of E8I (CIII-1,2).
In this study, we have focused on enhancer E8II (CIV- able from DP thymocytes by analysis of other surface
markers and by functional phenotype. The emergence4,5), which was shown to have activity in DP and CD8
SP thymocytes and in mature CD8 T cells (Ellmeier et of this subset of cells indicated that CD8 expression is
variegated in DP thymocytes of 12/12 mice. Sur-al., 1998). We wished to determine whether the E8II (CIV-
4,5) activity observed in transgenic mice reflects a prisingly, expression of CD8 on DP cells from 12/
12 mice was at a level similar to that from wild-typeunique and nonredundant function of this enhancer in
the regulation of CD8 and CD8 gene expression dur- littermates. These results reveal a previously unex-
pected function of two distinct enhancer elements, sug-ing the development of thymic-derived T cells. We found
that E8II (CIV-4,5)-deficient (2/2) mice had normal ex- gest that additional enhancers contribute to the initiation
cis Elements for the Initiation of CD8 Expression
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Figure 2. Normal T Cell Development and
CD8 Expression in 2/2 Mice
(A) Three-color flow cytometric analysis of
CD4, CD8, and CD3 expression on thymo-
cytes isolated from / and 2/2 litter-
mates. Upper panel: numbers in the dot plot
quadrants indicate the percentage of the cor-
responding thymocyte subpopulations (of to-
tal gated thymocytes). Lower panel: individ-
ual histograms showing CD3 expression on
gated thymocyte populations (gated popula-
tions are indicated in the upper left of each
histogram).
(B) Lymph node T cells were isolated from
/ and 2/2 littermates and analyzed by
two-color flow cytometry for expression of
CD4 and CD8. Numbers next to the gates
indicate the percentage of the corresponding
lymph node cell population (of total gated
cells).
(C) Diagram indicating the percentage of CD4
single-positive (SP, left panel), double-posi-
tive (DP, middle panel), and CD8 SP (right
panel) thymocytes in wild-type (/), hetero-
zygous (/2), and homozygous (2/2)
knockout mice.
(D) Diagram showing the CD4 to CD8 ratio of
lymph node T cells isolated from mice of the
indicated genotypes. In (C) and (D), each cir-
cle represents one mouse. Horizontal bars
indicate average value of each genotype.
of CD8 expression in DP thymocytes, and indicate that erated ES cells in which only a single loxP site remained
instead of E8II (CIV-4,5). Heterozygous /2 ES cellan active state of CD8 gene expression is epigenetically
maintained during development of DP thymocytes. clones were then selected for injection into C57Bl/6
blastocysts, and chimeric mice obtained from /2 ES
cells were backcrossed to C57Bl/6 mice for germlineResults
transmission. Heterozygous offspring were intercrossed
to obtain /, /2, and 2/2 mice. Mice were alsoGeneration of 2/2 Mice
generated from /N2 ES cells, and N2/N2 mice showedE8II (CIV-4,5) is located on a 4.3 kb genomic BamHI
the same phenotype as 2/2 mice (data not shown).fragment (Figure 1A) downstream of the CD8 gene (Ell-
meier et al., 1998). This fragment was deleted by homol-
ogous recombination in E14.1 ES cells (Figures 1B and Unaltered T Cell Development and CD8 Expression
in 2/2 Mice1C), and several targeted clones were isolated (desig-
nated /N2). Heterozygous /N2 ES cells were then The 4.3 kb genomic fragment containing E8II (CIV-4,5)
enhancer activity is able to direct the expression of atransiently transfected with Cre recombinase to delete
the neomycin selection cassette, which has the potential transgenic hCD2 reporter gene both in DP thymocytes
and mature CD8 T cells (Ellmeier et al., 1998). However,to interfere with the regulation of neighboring enhancer
and promoter elements (Sleckman et al., 1996). This gen- the deletion of E8II (CIV-4,5) had no effect on the thymic
Immunity
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Table 1. Relative Expression of CD8 and CD4 in Enhancer-Deficient Mice
Thymocyte Subset
Genotype Coreceptor DP CD8 SP CD4 SP Lymph Node
WT CD8 100 100 100
(n  5) CD4 100 100
2/2 CD8 94  18 89  23 102  19
(n  7)a CD4 94  20 107  15
12/12 CD8 80  13 75  14 68  5
(n  7) CD4 101  17 99  11
1/1 (n  6)b CD8 98  10 73  11 98  11
Numbers indicate the percentage of CD8 or CD4 expression levels (measured as ratios of mean fluorescence) of homozygous enhancer-
deficient mice relative to wild-type mice in thymic subpopulations and in lymph node T cells.
a n  5 for lymph node expression levels.
b Numbers were previously reported in Ellmeier et al., 1998.
(Figure 2A) or peripheral expression of CD8 (Figure 2B T cell development or on the expression of CD8 in thy-
mus-derived T cells. In contrast, thymocytes from dou-and Table 1). Furthermore, T cell development was nor-
mal and there was no difference in the relative abun- ble-deficient mice displayed a dramatic change in the
CD4 versus CD8 expression profile (Figures 3A and 3C).dance of the different T cell subsets compared to wild-
type mice (Figure 2C and data not shown). In addition, An increase in CD4 SP thymocytes was observed (from
11% to 29%), while the percentage of DP thymocytesthe expression of CD8 homodimers on IEL was similar
in wild-type and 2/2 mice (Figure 6B). decreased (from 84% to 65%). In addition, the percent-
age (from 4.5% to 1.8%; Figure 3C) and also the absolute
Generation of 12/12 Mice numbers (from 2.8  0.2 	 106 in /12 mice to 1.9 
The results from the analysis of 2/2 mice clearly indi- 0.2	 106 in 12/12 littermates; n 3 and 4, respec-
cated that other regulatory elements were able to com- tively) of CD8 SP thymocytes in the thymus of 12/
pensate for loss of E8II (CIV-4,5) enhancer activity. Other 12 mice were decreased. However, the total number
enhancers such as the mature CD8 enhancer E8I (CIII- of thymocytes in /12 and 12/12 mice was not
1,2) or the DP-specific enhancer E8III (CIV-3) are able to different from wild-type littermates (data not shown).
direct expression in similar T cell subsets as E8II (CIV- Changes in the percentage of CD4 versus CD8 T cells
4,5) does (Ellmeier et al., 1999). Thus, it is possible that were also observed in the periphery (Figure 3B). 12/
E8I (CIII-1,2) is able to compensate for loss of E8II (CIV- 12 mice had fewer CD8 T cells than their wild-type
4,5) in mature CD8 T cells, while E8III (CIV-3) might com- littermates, indicated by an increase in the CD4/CD8
pensate for the loss of E8II (CIV-4,5) in DP thymocytes. ratio in secondary lymphoid organs such as lymph
In fact, the normal expression of CD8 in thymus-derived nodes (from 1.7 to 3.6; Figures 3B and 3D) and spleen
T cell lineages in 1/1 mice (Ellmeier et al., 1998; Host- (data not shown). Lymph node T cells that still expressed
ert et al., 1998) indicates that elements exist which com- CD8 had approximately 70% of wild-type CD8 expres-
pensate for loss of E8I (CIII-1,2) as well. To test whether sion levels on their surface (Table 1). Furthermore, all
E8II (CIV-4,5) and E8I (CIII-1,2) have redundant functions CD8-expressing thymocytes and T cells expressed both
in the regulation of CD8 and CD8 gene expression, CD8 and CD8 (Figure 4E and data not shown).
we generated mice lacking both enhancers. There-
fore, /2 ES cells were transfected with the E8I (CIII-
“CD8-Negative” SP Thymocytes in 12/12 Mice1,2) targeting construct (Ellmeier et al., 1998), and E8I
The increase in the percentage of CD4 SP thymocytes(CIII-1,2)-targeted /2 ES cells were subsequently
could be explained by at least three mechanisms. Itscreened by Southern blotting to identify ES cells that
could be caused either by a loss of CD8 expression onhad both enhancers deleted at the same CD8 locus
DP thymocytes, by an increase in positive selection ofallele. Heterozygous/N12 ES cells were then injected
CD4 lineage cells, or even by a developmental switchinto C57Bl/6 blastocysts, and subsequently /N12
from the CD8 to CD4 T cell lineage caused by alterationsmice were obtained. To delete the neomycin expression
in the expression of CD8. To investigate whether onecassette, /N12 mice were crossed with transgenic
of these mechanisms was responsible for the alteredmice expressing Cre recombinase under the control of
thymic profile in 12/12 mice, we determined thethe CMV promoter (White et al., 1997). Heterozygous
developmental stage of the CD4 SP cells by examining/12 mice were then interbred to obtain /, /
the expression of CD3, HSA, CD69, and CD5. As pre-12, and 12/12 mice [see Figure 1D for the map
viously shown (Bendelac et al., 1992; Swat et al., 1993;of the CD8 locus after E8I (CIII-1,2) and E8II (CIV-4,5)
van Meerwijk and Germain, 1993; Yamashita et al., 1993),deletion]. Expression of CD8 was also analyzed in N12/
wild-type CD4 SP thymocytes have a CD3hi, HSAlo, CD5hi,N12 mice, and they had the same phenotype as 12/
and CD69/ surface phenotype (Figure 4B), while wild-12 mice (data not shown).
type DP thymocytes are CD3lo/med, HSAhi, CD5med, and
CD69/lo. CD4 SP thymocytes from 12/12 mice,Altered T Cell Development and CD8 Expression
however, displayed a bimodal expression pattern ofin 12/12 Mice
these surface molecules (Figure 4B), suggesting theDeletion of E8I (CIII-1,2) (Ellmeier et al., 1998; Hostert et
al., 1998) or E8II (CIV-4,5) individually had no effect on presence of two distinct subsets. In addition to the ma-
cis Elements for the Initiation of CD8 Expression
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Figure 3. Altered CD8 Expression and Re-
duced Numbers of CD8 SP Thymocytes and
CD8 T Cells in 12/12 Mice
(A) Flow cytometric analysis of CD4 and CD8
expression on thymocytes isolated from mice
of the same litter with the indicated genotype.
Numbers in the dot plot quadrants indicate
the percentage of the corresponding thymic
subpopulations (of total gated thymocytes).
(B) Lymph node T cells isolated from mice
of the indicated genotype were analyzed by
two-color flow cytometric analysis for the ex-
pression of CD4 and CD8. Gates show the
area of either CD4 or CD8 T cells. Numbers
next to the gates indicate the percentage of
the corresponding T cell subset.
(C) Diagram indicating the percentage of CD4
single-positive (SP, left panel), double-posi-
tive (DP, middle panel), and CD8 SP (right
panel) thymocytes in wild-type (/), hetero-
zygous (/12), and homozygous (12/
12) knockout mice.
(D) Diagram showing the CD4 to CD8 ratio of
lymph node T cells isolated from mice of the
indicated genotypes. In (C) and (D), each cir-
cle represents one mouse. Horizontal bars
indicate average value of each genotype.
ture CD4 SP thymocyte subset, a population of CD4 SP we took advantage of the existence of two allelic forms
of CD8 (and also CD8) that can be distinguished fromcells that were CD3lo, HSAhi, CD5med, and CD69neg was
detected. Thus, the surface phenotype of these addi- each other using specific antibodies. AKR.1 mice ex-
press the CD8.1 isoform, while C57Bl/6 (or 129/Sv)tional CD4 SP thymocytes is similar to DP thymocytes.
To test whether TCR engagement in the absence of both mice express CD8.2. Therefore, AKR.1 mice were
crossed with/12 mice (which are CD8.2), and sub-enhancers at the onset of positive selection caused the
downmodulation of CD8 on DP thymocytes, 12/12 sequently the F1 generation (either AKR.1/C57Bl/6 or
AKR.1/12C57Bl/6) was analyzed for the expression of themice were intercrossed with TCR-deficient mice (Mom-
baerts et al., 1992; Philpott et al., 1992). As shown in various CD8 alleles. As shown in Figure 4E, a popula-
tion of “CD8.2-negative” SP thymocytes was detectedFigure 4C, “CD8-negative” SP thymocytes were present
in 12/12-TCR null mice. This indicates that the only in AKR.1/12C57Bl/6 mice, thus showing that “CD8-
negative” SP thymocytes express neither CD8 noralterations in CD8 expression occurred at early stages
(i.e., before positive selection) of T cell development. CD8.
To functionally test whether the “CD8-negative” SP
thymocytes are indeed DP thymocytes that do not ex- Variegated Expression of CD8 in 12/12
DP Thymocytespress CD8, their sensitivity toward glucocorticoids was
determined. Dexamethasone injection caused the dis- Following  selection and proliferation of double-nega-
tive stage 3 (DN3) thymocytes, CD8 and CD4 are ex-appearance of both DP and “CD8-negative” SP thymo-
cytes after 48 hr but had no effect on CD4 SP cells in pressed and the cells progress to the DP stage. To follow
the development of “CD8-negative” SP thymocytes andcontrol mice (Figure 4D). In addition, “CD8-negative”
SP thymocytes and DP thymocytes from mutant mice DP thymocytes in 12/12 mice, fetal thymic organ
culture (FTOC) experiments were performed. E14.5 thy-displayed similar proliferative profiles in short-term
BrdU labeling experiments (data not shown). mic lobes from /12 and 12/12 mice were iso-
lated and cultured, and the appearance of cells express-We also wished to determine whether “CD8-negative”
SP thymocytes express CD8 (which requires CD8 for ing CD4 and CD8 was monitored over a period of several
days. The vast majority of /12 and 12/12 thy-surface expression). To test for the expression of CD8,
Immunity
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Figure 4. “CD8-Negative” SP Thymocytes in 12/12 Mice
(A) Three-color flow cytometric analysis of thymocytes isolated from / or 12/12 littermates. Numbers in the CD4 versus CD8 dot plot
quadrants indicate the percentage of the corresponding thymocyte subpopulations (of total gated thymocytes). Regions indicate gating areas
for the histograms shown in (B).
cis Elements for the Initiation of CD8 Expression
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Thus, “CD8-negative” SP thymocytes and DP cells in
12/12 mice appear to develop simultaneously.
E8I (CIII-1,2) and E8II (CIV-4,5) Direct CD8
Homodimer Expression in TCR IEL
It has previously been shown, both by transgenic re-
porter expression and targeted deletion in ES cells, that
E8I (CIII-1,2) is the major enhancer involved in the regula-
tion of CD8 expression on IEL (Ellmeier et al., 1998;
Hostert et al., 1998). However, a subset of IEL in 1/1
mice still shows low-level expression of CD8. Thus,
other enhancers must be involved in the regulation of
CD8 in IEL. However, as mentioned above and shown
in Figure 6B, E8II (CIV-4,5)-deficient IEL displayed normal
levels of CD8. In sharp contrast, double-deficient mice
essentially lost CD8 expression on IEL of the TCR

lineage (Figure 6A). A reduction of CD8 expression in
12/12 mice compared to 1/1 mice was also
observed on TCR-positive IEL (data not shown).
Discussion
Several enhancers within the CD8 locus have been
shown to direct expression of reporter genes in trans-
genic mice in a developmental stage-, subset-, and lin-
eage-specific fashion. Among these, E8I (CIII-1,2) is
active only in mature CD8 T cells and IELs, while E8II
Figure 5. Monitoring the Appearance of “CD8-Negative” SP Thymo- (CIV-4,5) is active both in mature CD8 T cells and DP
cytes thymocytes (Ellmeier et al., 1999). To understand the
Flow cytometric analysis of fetal thymic organ cultures. Thymic function and potential interactions of the different en-
lobes (E14.5) were isolated and cultured in vitro for the indicated time hancers at the endogenous locus in more detail, we
periods. Dot plots show the expression of CD4 and CD8 coreceptor
have employed gene targeting to delete enhancers inmolecules. Numbers in the dot plot quadrants indicate the percent-
the mouse germ line. In this study, we generated E8IIage of the corresponding thymic subpopulations (of total gated
(CIV-4,5) single (2/2) or E8I (CIII-1,2)/E8II (CIV-4,5) dou-thymocytes).
ble-deficient (12/12) mice and showed that these
two enhancers function together in an unexpected man-
ner in the establishment of CD8 expression in immaturemocytes were still at the DN stage after 1 day in culture
(Figure 5), although some immature CD8 SP (ISP) thymo- thymocytes. Single or double mutations had little effect
on CD8 expression in mature CD8 lineage T cells, andcytes were detected. After 3 days, a high percentage of
ISP and DP thymocytes but only few CD4 SP cells were single mutations also had no effect on expression of CD8
in thymocytes. However, deletion of both enhancers ledpresent in the/12 culture. In the12/12 culture,
DP thymocytes and ISP were also present. However, to the appearance of “CD8-negative” SP thymocytes
that, by several criteria, were shown to be DP thymo-there was an increase in the percentage of “CD8-nega-
tive” SP thymocytes, and therefore the ratio of CD4 SP cytes that do not express CD8. The concurrent appear-
ance of “CD8-negative” SP thymocytes and DP cells isto DP cells was much higher than in the/12 culture.
In addition, a decrease in the percentage of immature consistent with variegation of expression of CD8 in
12/12 DP thymocytes, which suggests that precur-CD8 SP 12/12 thymocytes was observed. The
emergence of “CD8-negative” SP thymocytes in 12/ sor cells in mutant mice undergo stochastic establish-
ment or loss of CD8 gene expression. As a consequence,12 cultures was even more pronounced after 7 days.
(B) Individual histograms showing expression of CD3, CD69, HSA, and CD5 (from top to bottom). Histograms above the dotted line show
expression in wild-type (/) thymocytes, while the lower rows of histograms indicate expression in 12/12 littermates. The thymocyte
subsets that were analyzed are indicated on the top of the histograms. Numbers in the histograms show the percentage of cells within the
indicated regions.
(C) Two-color flow cytometric analysis of CD4 and CD8 expression on thymocytes isolated from either /12 or 12/12 TCR-deficient
littermates. Numbers in the dot plot quadrants indicate the percentage of the corresponding thymocyte subpopulations (of total gated
thymocytes).
(D) Three-color flow cytometric analysis of thymocytes isolated from /12 or 12/12 mice 48 hr after i.p. injection of 600 g dexametha-
sone (top panels) or from noninjected controls (lower panel). Gating areas for the CD4 versus CD8 dot plots were either CD3-high or CD3-
low thymocytes.
(E) Three-color flow cytometric analysis of CD4 and CD8.12 and CD8.2 expression on thymocytes isolated from either / (upper panel)
or /12 (lower panel) (AKR.1 	 C57B/6-129) F1 mice. Numbers in the dot plot quadrants indicate the percentage of the corresponding
thymocyte subpopulations (of total gated thymocytes).
Immunity
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Figure 6. Enhancers E8I (CIII-1,2) and E8II (CIV-4,5) Regulate the Expression of CD8 on TCR
 IEL
Flow cytometric analysis of intestinal intraepithelial lymphocytes isolated from the various enhancer knockout mice. Cells were analyzed for
the expression of CD8, CD8, and TCR
.
(A) Histograms (right panel) show CD8 expression on gated TCR
 (and CD8) IEL isolated from /, /12, and 12/12 littermates.
The gate for TCR
 IEL is shown in the dot plot (left panel).
(B) Histograms show CD8 expression on gated TCR
 (and CD8) IEL isolated from / and 2/2 littermates.
(C) Histograms show CD8 expression on gated TCR
 (and CD8) IEL isolated from / and 1/1 littermates (as previously shown in
Ellmeier et al., 1998). For (B) and (C), a representative gate used for TCR
 IEL is shown in the dot plot in (A). The numbers above the marked
regions in the histograms indicate the percentage of CD8-positive cells within the gated populations, and the mean fluorescence of CD8
expression levels is shown in brackets.
fewer DP thymocytes were present and fewer mature al., 2001), the CD8 locus appears to be under the com-
plex control of a series of enhancer elements (EllmeierCD8 T cells developed. These results reveal a novel
function of enhancers that cannot be predicted by trans- et al., 1999). Based on the results from the transgenic
reporter expression assays, one would predict that indi-genic reporter analyses. They additionally suggest that
there is partial redundancy of enhancers involved in vidual deletions of either enhancer E8I (CIII-1,2) or E8II
(CIV-4,5) should lead (at least) to a reduction of CD8initiation of CD8 gene expression in ISP or DP thymo-
cytes. Even in the absence of both E8I (CIII-1,2) and E8II expression levels in peripheral cytotoxic T cells, while
the E8II (CIV-4,5) deletion should also affect the expres-(CIV-4,5), a majority of thymocytes expressed CD8 in
the DP compartment, suggesting that after initiation of sion of CD8 in the thymus. Conversely, CD8 expres-
expression, an epigenetic mechanism keeps the CD8 sion on IEL should be affected only by the deletion of
locus in an “on” configuration. E8I (CIII-1,2) but not of E8II (CIV-4,5). Furthermore, the
combined deletion of both E8I (CIII-1,2) and E8II (CIV-
4,5) should lead to a more dramatic reduction of CD8CD8 Expression in Thymocytes, Mature T Cells,
and IEL levels than the individual deletions. However, the normal
expression of CD8 in thymus-derived T cell lineagesIn contrast to the CD4 gene, which is regulated by devel-
opmental stage-specific activation of a silencer (Zou et in E8I (CIII-1,2)-deficient (1/1) mice indicated already
cis Elements for the Initiation of CD8 Expression
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that enhancer activities exist which can fully compen- even in the absence of TCR, alterations in CD8 expres-
sion must occur before the onset of positive selection.sate for loss of E8I (CIII-1,2) (Ellmeier et al., 1998; Hostert
The appearance of “CD8-negative” SP cells pointset al., 1998). E8II (CIV-4,5) directs expression in DP and
therefore to at least three potential mechanisms to ex-CD8 SP thymocytes as well as mature CD8 T cells
plain how differentiating thymocytes may employ the(Ellmeier et al., 1998), and thus the finding of normal
various CD8 enhancers during the developmental win-CD8 expression in its absence indicates compensatory
dow between the pre-TCR stage ( selection) and posi-enhancer activities not only in peripheral CD8 T cells
tive selection.but also in developing thymocytes. Since other en-
An explanation for the appearance of the “CD8-nega-hancers such as the mature CD8 enhancer E8I (CIII-1,2)
tive” SP cells that we cannot exclude at the presentor the DP-specific enhancer E8III (CIV-3) are able to direct
time is that there are at least two distinct subsets of DPexpression in similar T cell subsets as E8II (CIV-4,5) does
thymocytes. One subset would require E8I (CIII-1,2) and(Ellmeier et al., 1999), it is possible that E8I (CIII-1,2) and
E8II (CIV-4,5), while the other(s) would utilize differentE8III (CIV-3) can compensate for loss of E8II (CIV-4,5) in
cis-regulatory elements to express CD8 [such as E8IIImature CD8 T cells and DP thymocytes, respectively.
(CIV-3) and/or E8IV (CIV-1,2) or other unidentified ele-Based on the unexpected finding of largely normal CD8
ments]. This would be an unexpected finding, since itexpression in mature T cells of 12/12 mice, how-
is generally assumed that DP thymocytes are a homoge-ever, it is likely that additional enhancers can function
nous population before the onset of positive selection,in these cells to direct expression of CD8 and CD8.
at least with respect to CD4 and CD8 expression andIn addition, the observation of variegated expression of
their potential to develop into the helper or cytotoxicCD8 in 12/12 DP thymocytes, which is not pre-
lineages. A comparative analysis of the “CD8-negativedicted by the transgenic results, suggests additional
SP” and DP thymocytes on a TCR-deficient back-functions of the genomic enhancer fragments that can-
ground, e.g., by means of expression profiling, may helpnot be compensated by the activity of other cis ele-
to reveal whether subsets of DP thymocytes can bements.
separated based on differential utilization of CD8 en-We previously showed that E8I (CIII-1,2) is able to
hancers.direct expression in CD8 IEL in transgenic mice (Ell-
A second possibility is that the onset of CD8 expres-meier et al., 1997). Targeted deletion confirmed that E8I
sion is delayed in12/12 DN thymocytes, and there-(CIII-1,2) is the major enhancer that directs expression
fore a large fraction of thymocytes initially expressesof CD8 in this lineage (Ellmeier et al., 1998; Hostert et
only CD4. During developmental progression, other CD8al., 1998). A subset of CD8-expressing TCR
 IEL
enhancers such as E8III (CIV-3) may become activatedin 1/1 mice, however, still expressed CD8 homodi-
and direct expression of CD8 in DP thymocytes. Thismers (although at lower levels) on their surface (Ellmeier
“enhancer switching” model implies that developinget al., 1998). One possible explanation was that other
thymocytes utilize different enhancers during their pro-(unknown) enhancer elements are able to compensate
gression through the DP stage. Either E8I (CIII-1,2) orfor loss of E8I (CIII-1,2) in this particular CD8lowTCR

E8II (CIV-4,5) would be required at earlier stages of DPIEL subset. Surprisingly, enhancer E8II (CIV-4,5), which
thymocyte development, while at later stages DP cellsdid not show any activity in CD8 IEL in transgenic
would utilize other cis-regulatory elements. This modelmice (Ellmeier et al., 1998), was found to compensate,
predicts that “CD8-negative” SP cells are precursors ofat least partially, for loss of E8I (CIII-1,2). An almost
DP thymocytes and therefore appear before DP thymo-complete absence of CD8 expression in TCR
 IEL
cytes develop. This is not observed in FTOC experi-and a further reduction of CD8 expression in CD8T-
ments, in which “CD8-negative” SP thymocytes and DPCR IEL were observed in 12/12 mice. E8I (CIII- cells appeared simultaneously. Similar observations1,2) and E8II (CIV-4,5) are therefore the cis-regulatory have also been made when a new wave of DP thymocyteelements that direct expression of CD8 in CD8 homo-
development was monitored in 12/12 mice after
dimer-expressing IEL of the TCR
 lineage. In CD8
the depletion of DP cells by in vivo administration of
IEL of the TCR lineage, additional elements are able
dexamethasone (W.E., unpublished data). In addition,
to direct low-level expression of CD8. short-term BrdU labeling studies in mice showed that
Thus, although transgenic analysis of reporter genes both “CD8-negative” SP cells and DP thymocytes incor-
has suggested that enhancers may function in sequen- porated BrdU to a similar extent. Thus, the enhancer
tial stage-specific activation of the locus, the results switching model insufficiently explains the presence of
presented here suggest a more complex mechanism. “CD8-negative” SP thymocytes in 12/12 thymo-
E8I (CIII-1,2) appears to contribute to establishment of cytes.
CD8 expression in immature thymocytes even though We favor an alternative explanation to describe the
it fails to direct expression of reporter genes in thymus; phenotype of 12/12 mice, which is that E8I (CIII-
similarly, E8II (CIV-4,5) contributes to expression in IEL 1,2) and E8II (CIV-4,5) are involved in the initiation of
that is only revealed by analysis of mice with compound CD8 expression in DN thymocytes. In their absence,
mutations. thymocytes may only incompletely (i.e., only with a cer-
tain probability) initiate expression of CD8, and thus
How Do CD8 Enhancers Function only a certain percentage of DP cells express CD8. This
during T Cell Development? variegated expression of CD8 in the DP compartment
The finding of “CD8-negative” SP thymocytes and their is reminiscent of position effect variegation observed
developmental relationship to DP cells in 12/12 for transgenes (Festenstein and Kioussis, 2000). Thus,
mice may provide key insight into how the CD8 genes are E8I (CIII-1,2) and E8II (CIV-4,5) may participate in the
initiation of CD8 expression after  selection, e.g., byregulated in the thymus. Since these cells were present
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mediating chromatin remodeling at the CD8 locus due the absence of a specific mature enhancer. This would
not be unprecedented in the regulation of coreceptorto the recruitment of chromatin opening activities. Once
CD8 expression is established, thymocytes and mature gene expression, since it has been recently shown that
the CD4 silencer is required for the establishment butCD8 T cells would then maintain high-level stable ex-
pression of CD8 by a mechanism currently unknown. not the maintenance of CD4 silencing (Zou et al., 2001).
However, additional developmental stage-specific en-According to this “initiation/maintenance model,” “CD8-
negative” SP and DP thymocytes in 12/12 mice hancer activities, and therefore (at least) partial redun-
dancy, must exist. According to recent studies, DP thy-should develop simultaneously and should also display
a similar proliferative state. This is in agreement with mocytes that have received signals for positive selection
terminate CD8 expression, even if they differentiate intoobservations made with FTOC experiments and BrdU
labeling studies, respectively. Variegation of CD8 ex- CD8 T cells (Brugnera et al., 2000). Thus, thymocytes
that develop into cytotoxic T cells utilize lineage- andpression is observed as early as at the ISP stage in
FTOC. Thus, thymocytes that do not express CD8 in developmental stage-specific regulatory elements to re-
express CD8 (“coreceptor reversal”). One candidate ele-these precursors may be those that proceed directly to
the “CD8-negative” CD4 SP phenotype, which would ment involved in the reexpression of CD8 is the mature
CD8 enhancer E8I (CIII-1,2), which in transgenic miceindicate that an epigenetic decision occurs at this earlier
stage. gets activated during positive selection. However, previ-
ous studies (Ellmeier et al., 1998; Hostert et al., 1998)
and also this study indicate that in the absence of E8IAre Additional cis Elements Required for Initiating
(CIII-1,2) mature T cells are still able to reexpress CD8.CD8 Expression?
In addition, E8I (CIII-1,2) gets activated at the CD3hiHSAloThe initiation/maintenance model implies that some of
stage (Ellmeier et al., 1997; Hostert et al., 1997b), thus,the CD8 cis-regulatory elements may not be required
late during positive selection. Therefore, it is predictedto direct but rather to facilitate transcription (e.g., by
that additional regulatory elements (or combined activi-opening up the CD8 locus and thereby allowing tran-
ties) activate CD8 in maturing CD8 lineage cells and mayscription factors to bind to other cis elements). Similar
be operative even in the absence of E8I (CIII-1,2). Sinceobservations that different cis elements mediate differ-
at the endogenous CD8 locus, synergistic combinatorialent aspects in the regulation of gene expression (such
interactions occur between different cis-regulatory se-as opening of a gene locus versus high-level expression)
quences, further combined deletions of cis regions needhave also been described for the -globin locus (Bender
to be performed to reveal the identity of potential imma-et al., 2000; Engel and Tanimoto, 2000; Higgs, 1998).
ture and mature enhancer combinations.Since most thymocytes still express CD8 (along with
CD4) in the absence of E8I (CIII-1,2) and E8II (CIV-4,5),
additional elements at the CD8 locus must be involved Experimental Procedures
in facilitating CD8 expression. A candidate region for
Generation of /2 and /N12 ES cellssuch an element might be the DNase I hypersensitivity
Genomic clones containing various fragments from the CD8 locus(DH) site cluster II (CII-1,2,3) located immediately up-
were isolated from a 129 genomic library (Stratagene) and subcloned
stream of the CD8gene. Cluster II cannot direct expres- into pBluescript (pBS; Stratagene). The short (as a 0.9 kb BamHI/
sion of a reporter gene by itself (Hostert et al., 1997a), HindIII fragment) and the long (as a 6.0 kb BamHI/ClaI fragment)
but in combination with cluster III/E8I (CIII-1,2) (see Fig- arms of the E8II (CIV-4,5) targeting construct were sequentially
cloned into a pBS-based vector containing a polylinker with suitableure 1A) it directs expression not only in mature CD8
cloning sites and the thymidine kinase gene driven by the herpesT cells but also in DP thymocytes (Hostert et al., 1998).
simplex virus enhancer/promoter elements (Thomas and Capecchi,Targeted deletion of cluster II leads to a similar pheno-
1990). The neomycin resistance gene expression cassette flanked
type as observed in 12/12 mice (Garefalaki et al., by two loxP sites (Gu et al., 1993) was subsequently inserted (as a
2002), indicating that this region may indeed function 1.4 kb XhoI/SalI fragment) between the two arms. All cloning steps
as another regulatory element that facilitates the expres- were performed according to standard procedures. E14.1 ES cells
(Kuhn et al., 1991) were transfected as previously described (Ellmeiersion of CD8 in DP thymocytes.
et al., 1998), and proper targeting of ES cells (designated /N2)
was detected by Southern blotting. The deletion of the neomycinMaintenance of CD8 Expression
resistance gene was achieved by transient transfection of 20 g Cre
An important question that remains to be addressed is recombinase into/N2 ES cells. Two days after Cre transfection, ES
how the expression of CD8 is maintained in 12/12 cells were replated onto 10 cm dishes at a density of 300 colonies/
plate. Individual clones were isolated, expanded, and G418-sensi-DP and CD8 SP thymocytes, and in mature CD8 T cells.
tive ES cells were analyzed by Southern blotting to confirm properThe expression of CD8 in 12/12 DP thymocytes
deletion of neomycin (designated /2).appears to remain stable even in the absence of positive
For the generation of /N12 ES cells, /2 ES cells were trans-selection, since 12/12 DP TCR null thymocytes
fected with the E8I (CIII-1,2) targeting vector and screened as pre-reexpress both CD4 and CD8 after pronase treatment viously described (Ellmeier et al., 1998). After the isolation of single
(W.E., unpublished data). One possibility is that after colonies, Southern blot analysis was performed to confirm proper
targeting (Ellmeier et al., 1998) and also that both enhancers werethe establishment of an open CD8 locus, additional cis
targeted on the same chromosomal allele. The various ES cell cloneselements, such as E8III (CIV-3), E8IV (CIV-1,2), or yet un-
(/2 and/N12) were injected into E3.5 C57Bl/6 blastocysts andknown enhancers, are sufficient to direct expression of
transferred into (B6/D2) F1 pseudo-pregnant females. Chimeric miceCD8. Alternatively, but not mutually exclusive, chromatin
obtained were then backcrossed to C57Bl/6, and transmission of the
remodeling events and subsequent establishment of targeted allele was confirmed by PCR and Southern blot analyses of
CD8 expression in thymocytes may result in an epige- tail DNA. The neomycin expression cassette at the E8I (CIII-1,2)
locus was deleted by crossing heterozygous /N12 mice withnetic change that keeps the CD8 locus active even in
cis Elements for the Initiation of CD8 Expression
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transgenic mice expressing Cre recombinase under the control of Chan, S.H., Waltzinger, C., Baron, A., Benoist, C., and Mathis, D.
(1994). Role of coreceptors in positive selection and lineage commit-the CMV promoter (White et al., 1997). The deletion of neomycin
was confirmed by PCR analysis (PCR products 2 and 3 in Figure 1, ment. EMBO J. 13, 4482–4489.
Ellmeier et al., 1998) and by Southern blotting. Corbella, P., Moskophidis, D., Spanopoulou, E., Mamalaki, C., To-
laini, M., Itano, A., Lans, D., Baltimore, D., Robey, E., and Kioussis,
Flow Cytometric Analysis and Antibodies D. (1994). Functional commitment to helper T cell lineage precedes
Cell suspensions were prepared from thymus, lymph nodes, or positive selection and is independent of T cell receptor MHC speci-
spleen and stained with the appropriate antibodies. The following ficity. Immunity 1, 269–276.
antibodies were used: PE-anti-mCD8 (CT-CD8), FITC- or PE-anti-
Davis, C.B., Killeen, N., Crooks, M.E., Raulet, D., and Littman, D.R.
mCD8.12 (CT-CD8), FITC-anti-mCD69 (H1.2F3), TC-anti-mCD4
(1993). Evidence for a stochastic mechanism in the differentiation
(CT-CD4), FITC-anti-mCD3 (Clone 500-A2), PE-anti-B220 (RA3-6B2),
of mature subsets of T lymphocytes. Cell 73, 237–247.
bio-anti-mTCR
 (GL3), TC-streptavidin and FITC-streptavidin from
Donda, A., Schulz, M., Burki, K., De Libero, G., and Uematsu, Y.Caltag, FITC- or bio-anti-HSA (M1/69), FITC-anti-mCD8.2 (53-5.8)
(1996). Identification and characterization of a human CD4 silencer.bio-anti-CD69 (H1.2F3), bio-anti-mTCR
 (GL3), PE-anti-CD5 (53-
Eur. J. Immunol. 26, 493–500.7.3), and bio-anti-mTCR (H57-597) from Pharmingen, and FITC-
anti-BrdU from Becton Dickinson. Cells were analyzed using Becton Ellmeier, W., Sunshine, M.J., Losos, K., Hatam, F., and Littman, D.R.
Dickinson FACScan flow cytometer and Cell Quest software. (1997). An enhancer that directs lineage-specific expression of CD8
in positively selected thymocytes and mature T cells. Immunity 7,
537–547.Fetal Thymic Organ Culture
Thymic lobes from embryos (E14.5) of various genotypes were iso- Ellmeier, W., Sunshine, M.J., Losos, K., and Littman, D.R. (1998).
lated and cultured in a humidified box on 0.45 m nylon filters Multiple developmental stage-specific enhancers regulate CD8 ex-
(Millipore) on top of gel foam (Upjohn) at 37C in RPMI-10% FCS. pression in developing thymocytes and in thymus-independent
At various time points during the culture period, single-cell suspen- T cells. Immunity 9, 485–496.
sions were made from individual thymic lobes and stained with
Ellmeier, W., Sawada, S., and Littman, D.R. (1999). The regulationappropriate antibodies for FACS analysis.
of CD4 and CD8 coreceptor gene expression during T cell develop-
ment. Annu. Rev. Immunol. 17, 523–554.
Dexamethasone Injections
Engel, J.D., and Tanimoto, K. (2000). Looping, linking, and chromatinMice were injected i.p. with 600 g Dexamethasone (Sigma) in 500
activity: new insights into beta-globin locus regulation. Cell 100,l PBS. Cell suspensions were made from the thymus at various
499–502.and stained with appropriate antibodies for FACS analysis.
Festenstein, R., and Kioussis, D. (2000). Locus control regions and
epigenetic chromatin modifiers. Curr. Opin. Genet. Dev. 10, 199–203.Isolation of Intestinal Intraepithelial Lymphocytes
IEL were isolated and purified by 37% Percoll centrifugation (at Garefalaki, A., Coles, M., Hirschberg, S., Mavria, G., Norton, T.,
1750 rpm for 30 min at room temperature) as described previously Hostert, A., and Kioussis, D. (2002). Variegated expression of CD8
(Ellmeier et al., 1997). Cells were washed twice with staining buffer, resulting from in situ deletion of regulatory sequences. Immunity
incubated for 5 min with Fc-block (Pharmingen), and subsequently 16, this issue, 635–647.
stained with antibodies.
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